Recap: TherapeuticsMD Q3 Earnings

 

TherapeuticsMD (NASDAQ:TXMD) reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

TherapeuticsMD their estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1, which did not surprise analysts.

Revenue was up $6,064,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0, which was followed by a 3.07% increase in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.